Regulation of GLP-1 and Glucagon Receptor Function by β-Arrestins in Metabolically Important Cell Types
Liu Liu,
No information about this author
Muhammad Rashid,
No information about this author
Jürgen Wess
No information about this author
et al.
Biochemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 21, 2025
Glucagon-like
peptide-1
(GLP-1)
and
glucagon
(GCG)
are
polypeptides
derived
from
a
common
precursor
(preproglucagon)
that
modulates
the
activity
of
numerous
cell
types
involved
in
regulating
glucose
energy
homeostasis.
GLP-1
GCG
exert
their
biological
functions
via
binding
to
specific
G
protein-coupled
receptors
(GLP-1Rs
GCGRs).
Ligand-activated
GLP-1Rs
GCGRs
preferentially
activate
heterotrimeric
protein
Gs,
resulting
increased
cytosolic
cAMP
levels.
However,
activation
two
also
leads
recruitment
β-arrestin-1
-2
(βarr1
βarr2,
respectively)
intracellular
surface
receptor
proteins.
The
β-arrestins
activated
contributes
termination
receptor-stimulated
coupling.
In
addition,
receptor-β-arrestin
complexes
can
act
as
signaling
nodes
own
right
by
modulating
many
pathways.
this
Review,
we
will
discuss
roles
βarr1
βarr2
key
metabolic
mediated
GCGRs.
During
past
decade,
GLP-1R
agonists
have
emerged
highly
efficacious
antidiabetic
antiobesity
drugs.
Moreover,
dual
stimulate
both
predicted
offer
additional
therapeutic
benefits
compared
agonist
monotherapy.
We
summarize
try
synthesize
series
studies
suggesting
development
protein-biased
and/or
GCGR
agonists,
which
do
not
lead
β-arrestins,
may
even
more
agents.
Language: Английский
Yerba Mate (Ilex paraguariensis St. Hill.) Tea May Have Cardiometabolic Beneficial Effects in Healthy and At‐Risk Subjects: A Randomized, Controlled, Blind, Crossover Trial in Nonhabitual Consumers
Molecular Nutrition & Food Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 22, 2025
ABSTRACT
Yerba
mate
has
been
reported
to
have
antihypertensive,
hypocholesterolemic,
antidiabetic,
or
antiobesity
properties.
Most
evidences
from
human
trials
involved
intakes
of
high
amounts
by
habitual
consumers.
Considering
its
increasing
popularity,
this
study
aimed
at
assessing
the
potential
cardiometabolic
effects
moderate
intake
yerba
nonhabitual
A
randomized,
crossover,
controlled
was
carried
out
in
healthy
and
hypercholesterolemic
subjects.
Anthropometric
parameters,
blood
pressure,
lipids,
glucose
metabolism,
inflammatory
cytokines,
chemokines,
different
markers
endothelial
function,
as
well
incretins,
adipocytokines,
hormones
were
measured
baseline
after
8
weeks
consuming
a
decaffeinated
isotonic
drink
(control).
After
daily
consumption
three
servings
tea,
colony‐stimulating
factors
decreased
all
participants.
LDL‐C
normocholesterolemic
individuals,
while
control
interventions
elicited
similar
hypolipidemic
action
group.
Ghrelin
glucose‐dependent
insulinotropic
polypeptide
(GIP)
significantly
intake,
glucagon‐like
peptide
1
(GLP‐1)
adipocytokines
remained
unchanged.
Body
fat
percentage
tricipital
skinfold
only
subjects,
with
no
on
total
body
weight.
In
conclusion,
could
exert
protective
consumers
subjects
cardiovascular
risk.
Trial
Registration
:
This
trial
retrospectively
registered
ClinicalTrials
(NCT06729905)
Language: Английский